{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:46:42Z","timestamp":1792525602923,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.rdc.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T18:22:19Z","timestamp":1669054939000},"page":"45-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases"],"prefix":"10.1016","volume":"49","author":[{"given":"Alexia A.","family":"Zagouras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/rheumatology\/keaa537","article-title":"Systemic autoimmune disease as a cause of death: mortality burden and comorbidities","volume":"60","author":"Mitratza","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.autrev.2017.12.001","article-title":"Cardiovascular involvement in systemic rheumatic diseases: an integrated view for the treating physicians","volume":"17","author":"Lee","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.autrev.2019.02.002","article-title":"Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases","volume":"18","author":"De Lorenzis","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2022.08.002_bib4","series-title":"Myocarditis: pathogenesis, diagnosis and treatment","first-page":"195","article-title":"Myocarditis in systemic immune-mediated diseases","author":"Caforio","year":"2020"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/acr.20322","article-title":"Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin","volume":"63","author":"Bartoloni","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2631","article-title":"The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus","volume":"11","author":"Full","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-09-0274","article-title":"Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis","volume":"73","author":"Ku","year":"2009","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","article-title":"Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/rheumatology\/keq005","article-title":"Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease","volume":"49","author":"Breland","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"10.1016\/j.rdc.2022.08.002_bib11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary microvascular dysfunction: mechanisms and functional assessment","volume":"12","author":"Camici","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.rdc.2022.08.002_bib14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/cvr\/cvy038","article-title":"Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening","volume":"114","author":"Sorop","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"22","key":"10.1016\/j.rdc.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.3390\/ijms20225563","article-title":"Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases","volume":"20","author":"Zanatta","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.rdc.2022.08.002_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2010.09.074","article-title":"Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins","volume":"57","author":"Vaccarino","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1540-8175.2012.01797.x","article-title":"Association between serum total antioxidant status and coronary microvascular functions in patients with SLE","volume":"29","author":"Y\u0131lmaz","year":"2012","journal-title":"Echocardiography"},{"key":"10.1016\/j.rdc.2022.08.002_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.phrs.2018.05.016","article-title":"uPA\/uPAR signaling in rheumatoid arthritis: Shedding light on its mechanism of action","volume":"134","author":"Dinesh","year":"2018","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.rdc.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/1354750X.2012.728623","article-title":"Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus","volume":"17","author":"Toldi","year":"2012","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2014.12.025","article-title":"Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"239","author":"Mekonnen","year":"2015","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.rdc.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vph.2012.12.001","article-title":"The Fra-2 transgenic mouse model of systemic sclerosis","volume":"58","author":"Maurer","year":"2013","journal-title":"Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.38942","article-title":"Cardiomyopathy in murine models of systemic sclerosis","volume":"67","author":"Venalis","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"23","key":"10.1016\/j.rdc.2022.08.002_bib24","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","article-title":"Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis","volume":"120","author":"Maurer","year":"2009","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.rdc.2022.08.002_bib25","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2020.10.022","article-title":"Reduced lymphatic reserve in heart failure with preserved ejection fraction","volume":"76","author":"Giacomo","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rdc.2022.08.002_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fimmu.2019.00519","article-title":"Lymphatic function in autoimmune diseases","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.humpath.2009.08.009","article-title":"Lymphatic and blood vessels in scleroderma skin, a morphometric analysis","volume":"41","author":"Rossi","year":"2010","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrrheum.2017.205","article-title":"Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis","volume":"14","author":"Bouta","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2022.08.002_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2018.12.005","article-title":"Lethal immunoglobulins: autoantibodies and sudden cardiac death","volume":"18","author":"Ryabkova","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2022.08.002_bib31","first-page":"1","article-title":"Autoimmune myocarditis, valvulitis, and cardiomyopathy","author":"Myers","year":"2013","journal-title":"Curr Protoc Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11897-014-0217-5","article-title":"Autoantibodies and cardiovascular dysfunction: cause or consequence?","volume":"11","author":"Nagatomo","year":"2014","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib33","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.4049\/jimmunol.172.5.3225","article-title":"Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat","volume":"172","author":"Li","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/08916930802031579","article-title":"Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies","volume":"41","author":"Mascaro-Blanco","year":"2008","journal-title":"Autoimmunity"},{"issue":"9","key":"10.1016\/j.rdc.2022.08.002_bib35","doi-asserted-by":"crossref","first-page":"85851","DOI":"10.1172\/jci.insight.85851","article-title":"Cardiac myosin-Th17 responses promote heart failure in human myocarditis","volume":"1","author":"Myers","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib36","doi-asserted-by":"crossref","first-page":"e006155","DOI":"10.1161\/CIRCHEARTFAILURE.119.006155","article-title":"\u03b21-adrenoreceptor autoantibodies in heart failure: physiology and therapeutic implications","volume":"13","author":"D\u00fcngen","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2016.03.005","article-title":"Autoantibodies specifically against \u03b21 adrenergic receptors and adverse clinical outcome in patients with chronic systolic heart failure in the \u03b2-blocker era: the importance of immunoglobulin G3 subclass","volume":"22","author":"Nagatomo","year":"2016","journal-title":"J\u00a0Card Fail"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib38","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.rdc.2022.08.002_bib39","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"issue":"10188","key":"10.1016\/j.rdc.2022.08.002_bib40","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","article-title":"Cardiac manifestations of systemic lupus erythematosus","volume":"40","author":"Miner","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.160493","article-title":"Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients","volume":"44","author":"Thomas","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(75)90575-6","article-title":"The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients","volume":"58","author":"Bulkley","year":"1975","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203312462265","article-title":"The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis","volume":"22","author":"Mavrogeni","year":"2013","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.rdc.2022.08.002_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jcp.2009.064311","article-title":"Cardiac pathology of systemic lupus erythematosus","volume":"62","author":"Jain","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib46","first-page":"489","article-title":"Differential associations of chronic inflammatory diseases with incident heart failure","volume":"8","author":"Prasada","year":"2020","journal-title":"JACC: Heart Fail"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib47","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s10067-016-3373-z","article-title":"Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis","volume":"35","author":"Chen","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10238-019-00600-8","article-title":"Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease","volume":"20","author":"Leone","year":"2020","journal-title":"Clin Exp Med"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/clc.22218","article-title":"Aortic stiffness is associated with left ventricular diastolic dysfunction in systemic lupus erythematosus: a controlled transesophageal echocardiographic study","volume":"37","author":"Roldan","year":"2014","journal-title":"Clin Cardiol"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0961203315622275","article-title":"Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study","volume":"25","author":"Seneviratne","year":"2016","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib51","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0961203312446628","article-title":"SLICC\/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus","volume":"21","author":"Shang","year":"2012","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.rdc.2022.08.002_bib52","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1177\/0961203320947805","article-title":"Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage","volume":"29","author":"Chorin","year":"2020","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tcm.2017.08.015","article-title":"Heart failure in systemic lupus erythematosus","volume":"28","author":"Dhakal","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.rdc.2022.08.002_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bpobgyn.2019.09.001","article-title":"Autoimmune-mediated congenital heart block","volume":"64","author":"Wainwright","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198307283090403","article-title":"Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block","volume":"309","author":"Scott","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2005.11.115","article-title":"Congenital complete heart block and maternal connective tissue disease","volume":"112","author":"Jayaprasad","year":"2006","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of Anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.rdc.2022.08.002_bib59","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.rdc.2022.08.002_bib60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"issue":"10 Suppl 1","key":"10.1016\/j.rdc.2022.08.002_bib61","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"Gabriel","year":"2008","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib62","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.amjmed.2020.02.039","article-title":"Outcomes of acute myocardial infarction in patients with rheumatoid arthritis","volume":"133","author":"Elbadawi","year":"2020","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2022.08.002_bib64","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7326\/0003-4819-58-1-102","article-title":"The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of sixty-two cases","volume":"58","author":"Lebowitz","year":"1963","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib65","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.23720","article-title":"A\u00a073-year-old woman with rheumatoid arthritis and shortness of breath","volume":"59","author":"Pappas","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib66","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping","volume":"8","author":"Ntusi","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.rdc.2022.08.002_bib67","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1007\/s00330-017-4838-4","article-title":"Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis","volume":"27","author":"Greulich","year":"2017","journal-title":"Eur Radiol"},{"issue":"10103","key":"10.1016\/j.rdc.2022.08.002_bib68","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib69","first-page":"882","article-title":"Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group","volume":"56","author":"Bissell","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semarthrit.2010.08.004","article-title":"Pulmonary hypertension in systemic sclerosis","volume":"41","author":"Chatterjee","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"145","key":"10.1016\/j.rdc.2022.08.002_bib71","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0056-2017","article-title":"Pulmonary hypertension in systemic sclerosis: different phenotypes","volume":"26","author":"Launay","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib72","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.00091212","article-title":"High prevalence of occult left heart disease in scleroderma-pulmonary hypertension","volume":"42","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/2045893217700438","article-title":"Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction","volume":"7","author":"Bourji","year":"2017","journal-title":"Pulm Circ"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib74","doi-asserted-by":"crossref","first-page":"102507","DOI":"10.1016\/j.autrev.2020.102507","article-title":"Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: derivation and internal validation","volume":"19","author":"Rubio-Rivas","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib75","first-page":"269","article-title":"Assessment of left and right ventricular diastolic function in patients with systemic sclerosis","volume":"66","author":"Ciurzy\u0144ski","year":"2008","journal-title":"Kardiol Pol"},{"issue":"15","key":"10.1016\/j.rdc.2022.08.002_bib76","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","article-title":"Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis","volume":"72","author":"Tenn\u00f8e","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/rheumatology\/keh087","article-title":"Blunted coronary flow reserve in systemic sclerosis","volume":"43","author":"Sulli","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2022.08.002_bib78","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.55.7.455","article-title":"Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve","volume":"55","author":"Valentini","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.autrev.2018.09.002","article-title":"Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: a newsworthy association","volume":"18","author":"Zanatta","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib80","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003792","article-title":"Unique Abnormalities in right ventricular longitudinal strain in systemic sclerosis patients","volume":"9","author":"Mukherjee","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.rdc.2022.08.002_bib81","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/art.30614","article-title":"Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias","volume":"63","author":"Yiu","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","article-title":"Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography","volume":"54","author":"Rodr\u00edguez-Reyna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12872-017-0619-x","article-title":"Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria","volume":"17","author":"Mavrogeni","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.rdc.2022.08.002_bib84","series-title":"StatPearls","article-title":"Scleroderma and primary myocardial disease","author":"Mohameden","year":"2020"},{"issue":"5 Suppl 62","key":"10.1016\/j.rdc.2022.08.002_bib85","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib86","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/art.1780240506","article-title":"Association of myositis and myocarditis in progressive systemic sclerosis","volume":"24","author":"West","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2022.08.002_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez658","article-title":"Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis","author":"De Luca","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib88","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.141.2.321","article-title":"Human autoantibodies reveal titin as a chromosomal protein","volume":"141","author":"Machado","year":"1998","journal-title":"J\u00a0Cell Biol"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib90","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib91","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3899\/jrheum.100767","article-title":"Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis","volume":"38","author":"Manetti","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib92","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rdc.2013.10.006","article-title":"The heart in vasculitis","volume":"40","author":"Miloslavsky","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib94","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaip.2020.07.038","article-title":"Antineutrophil cytoplasmic antibodies and organ-specific manifestations in eosinophilic granulomatosis with polyangiitis: a systematic review and meta-analysis","volume":"9","author":"Chang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib95","first-page":"e2792","article-title":"Eosinophilic myocarditis demonstrated using cardiac magnetic resonance imaging in a patient with eosinophilic granulomatosis with polyangiitis (churg-strauss disease)","volume":"10","author":"Dalia","year":"2018","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib96","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib97","first-page":"91","article-title":"Cardiac involvement in eosinophilic granulomatosis with polyangitis (Churg Strauss) (RCD code: I-3A.7a)","volume":"1","author":"Szczeklik","year":"2014","journal-title":"J\u00a0Rare Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib98","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.27263","article-title":"Cardiac involvement in Churg-Strauss syndrome","volume":"62","author":"Dennert","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2022.08.002_bib99","first-page":"493","article-title":"[Cardiac involvement in Churg-Strauss syndrome]","volume":"16","author":"Brucato","year":"2015","journal-title":"G\u00a0Ital Cardiol (Rome)"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A\u00a0vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib101","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.jaci.2018.11.041","article-title":"Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis","volume":"143","author":"Steinfeld","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2022.08.002_bib103","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3899\/jrheum.141513","article-title":"Cardiac involvement in granulomatosis with polyangiitis","volume":"42","author":"McGeoch","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2022.08.002_bib106","doi-asserted-by":"crossref","first-page":"6501738","DOI":"10.1155\/2017\/6501738","article-title":"Granulomatosis with polyangiitis with myocarditis and ventricular tachycardia","volume":"2017","author":"Hanna","year":"2017","journal-title":"Case Rep Med"},{"key":"10.1016\/j.rdc.2022.08.002_bib107","first-page":"134529","article-title":"Acute myocarditis in a patient with newly diagnosed granulomatosis with polyangiitis","volume":"2015","author":"Munch","year":"2015","journal-title":"Case Rep Cardiol"},{"issue":"19","key":"10.1016\/j.rdc.2022.08.002_bib108","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.rdc.2022.08.002_bib109","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4065\/80.11.1435","article-title":"Echocardiographic findings in patients with wegener granulomatosis","volume":"80","author":"Oliveira","year":"2005","journal-title":"Mayo Clinic Proc"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib110","first-page":"259","article-title":"One year in review 2015: Sj\u00f6gren\u2019s syndrome","volume":"33","author":"Luciano","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib111","first-page":"124","article-title":"Primary sj\u00f6gren\u2019s syndrome and the risk of acute myocardial infarction: a nationwide study","volume":"29","author":"Chiang","year":"2013","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/joim.12346","article-title":"Cardiovascular disease risk burden in primary Sj\u00f6gren\u2019s syndrome: results of a population-based multicentre cohort study","volume":"278","author":"Bartoloni","year":"2015","journal-title":"J\u00a0Intern Med"},{"issue":"7","key":"10.1016\/j.rdc.2022.08.002_bib113","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.55.7.450","article-title":"Cardiac manifestations in primary Sj\u00f6gren\u2019s syndrome","volume":"55","author":"Gy\u00f6ngy\u00f6si","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib114","first-page":"109","article-title":"Is the heart affected in primary Sj\u00f6gren\u2019s syndrome? An echocardiographic study","volume":"26","author":"Vassiliou","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/1756-185X.12049","article-title":"Assessment of left ventricular functions in patients with Sj\u00f6gren\u2019s syndrome using tissue Doppler echocardiography","volume":"16","author":"Bayram","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"9173","key":"10.1016\/j.rdc.2022.08.002_bib116","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(99)02251-5","article-title":"Myocarditis and primary Sj\u00f6gren\u2019s syndrome","volume":"354","author":"Levin","year":"1999","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rdc.2022.08.002_bib117","first-page":"707","article-title":"Primary Sj\u00f6gren\u2019s syndrome complicated with cryoglobulinemic glomerulonephritis, myocarditis, and multi-organ involvement","volume":"103","author":"Kau","year":"2004","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"Suppl 126","key":"10.1016\/j.rdc.2022.08.002_bib118","first-page":"95","article-title":"Autoimmune congenital heart block and primary Sj\u00f6gren\u2019s syndrome: characterisation and outcomes of 49 cases","volume":"38","author":"Brito-Zer\u00f3n","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"35","key":"10.1016\/j.rdc.2022.08.002_bib119","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"7\u20138","key":"10.1016\/j.rdc.2022.08.002_bib121","first-page":"377","article-title":"Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib122","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"issue":"10 Pt 1","key":"10.1016\/j.rdc.2022.08.002_bib123","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib124","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/heartjnl-2015-307877","article-title":"Diagnosis and treatment of cardiac sarcoidosis","volume":"102","author":"Kusano","year":"2016","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib126","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/europace\/eun110","article-title":"Ventricular tachyarrhythmia as a primary presentation of sarcoidosis","volume":"10","author":"Uusimaa","year":"2008","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.rdc.2022.08.002_bib127","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.rdc.2022.08.002_bib128","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/714321","article-title":"Cardiovascular risk in patients with psoriatic arthritis","volume":"2012","author":"Zhu","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib129","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib130","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3899\/jrheum.100034","article-title":"Mortality in psoriatic arthritis \u2013 a single-center study from the UK","volume":"37","author":"Buckley","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.berh.2019.01.002","article-title":"Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis","volume":"32","author":"Liew","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib132","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.rdc.2022.08.002_bib133","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib134","first-page":"127","article-title":"Inflammatory myopathies","volume":"113","author":"Atluri","year":"2016","journal-title":"Mo Med"},{"issue":"11","key":"10.1016\/j.rdc.2022.08.002_bib135","first-page":"686","article-title":"Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review","volume":"35","author":"Zhang","year":"2012","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib136","first-page":"373","article-title":"Cardiac manifestations in dermato-polymyositis","volume":"14","author":"Gonzalez-Lopez","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2022.08.002_bib137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2005.038679","article-title":"Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ehf2.12141","article-title":"Giant cell myocarditis masquerading as orbital myositis with a rapid, fulminant course necessitating mechanical support and heart transplantation","volume":"4","author":"Garg","year":"2017","journal-title":"ESC Heart Fail"},{"issue":"18","key":"10.1016\/j.rdc.2022.08.002_bib139","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Dank\u00f3","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib141","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2022.08.002_bib142","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib143","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/ajcp\/aqaa253","article-title":"Chloroquine- and hydroxychloroquine-induced cardiomyopathy: a case report and brief literature review","volume":"155","author":"Nadeem","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib144","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"25","key":"10.1016\/j.rdc.2022.08.002_bib145","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.rdc.2022.08.002_bib146","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejim.2012.12.015","article-title":"Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases","volume":"24","author":"Sinagra","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.rdc.2022.08.002_bib147","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1388-9842(02)00121-6","article-title":"Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH","volume":"4","author":"Coletta","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.rdc.2022.08.002_bib148","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib149","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13104-017-2726-2","article-title":"Role of metabolites of cyclophosphamide in cardiotoxicity","volume":"10","author":"Kurauchi","year":"2017","journal-title":"BMC Res Notes"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10741-015-9502-y","article-title":"Chemotherapy-induced cardiomyopathy","volume":"20","author":"Higgins","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"33","key":"10.1016\/j.rdc.2022.08.002_bib151","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.rdc.2022.08.002_bib152","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","article-title":"Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis","volume":"56","author":"Bissell","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rdc.2022.08.002_bib153","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"Hamzeh","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rdc.2022.08.002_bib154","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis","volume":"50","author":"Baker","year":"2020","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X22000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:30:41Z","timestamp":1760182241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X22000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0889857X22000710"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2022.08.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}